Antagonists of activin signaling: mechanisms and potential biological applications
- 31 March 2005
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 16 (2), 73-78
- https://doi.org/10.1016/j.tem.2005.01.003
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7Molecular Pharmacology, 2002
- Effect of Adenovirus-Mediated Overexpression of Follistatin and Extracellular Domain of Activin Receptor Type II on Gonadotropin Secretion in Vitro and in VivoEndocrinology, 2002
- Follistatin: Essential Role for the N-terminal Domain in Activin Binding and NeutralizationJournal of Biological Chemistry, 2001
- TGF-β3 in the Treatment of Pressure Ulcers: A Preliminary ReportAdvances in Skin & Wound Care, 2001
- Follistatin Is a Modulator of Gonadal Tumor Progression and the Activin-Induced Wasting Syndrome in Inhibin-Deficient MiceEndocrinology, 2000
- Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor IIEndocrinology, 1999
- Activin signaling through activin receptor type II causes the cachexia- like symptoms in inhibin-deficient miceMolecular Endocrinology, 1996
- Strong Induction of Activin Expression after Injury Suggests an Important Role of Activin in Wound RepairDevelopmental Biology, 1996
- Follistatin, an antagonist of activin, is expressed in the Spemann organizer and displays direct neuralizing activityCell, 1994
- α-lnhibin is a tumour-suppressor gene with gonadal specificity in miceNature, 1992